Literature DB >> 2137670

Tyrosine- and phenylalanine-restricted formula diet augments immunocompetence in healthy humans.

J R Norris1, G G Meadows, L K Massey, J R Starkey, D M Sylvester, S Y Liu.   

Abstract

Previous studies indicate that limiting tyrosine and phenylalanine intake in the diet decreases tumor growth and metastasis. General health status, immune status, and platelet function were studied in nine healthy human subjects consuming low-protein foods supplemented with formula diets free of tyrosine and phenylalanine to maintain total daily intake of tyrosine at 2.4 mg/kg body wt and phenylalanine at 3.5 mg/kg body wt. This regimen decreased plasma tyrosine (p less than 0.05) but not phenylalanine. Blood indicators of protein status were not changed. Platelet aggregation decreased in response to adenosine diphosphate and platelet activating factor in seven of nine subjects. Natural killer, T-helper, and T-cytotoxic/suppressor lymphocyte numbers proportionally increased relative to neutrophils (p less than 0.05). Natural killer cell activity increased in six of nine subjects. Increased natural killer cell activity and decreased platelet aggregation are two indices associated with decreased tumor growth and metastasis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2137670     DOI: 10.1093/ajcn/51.2.188

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  3 in total

1.  Immunological abnormalities in a patient with tyrosinaemia type III.

Authors:  P D D'Eufemia; R Finocchiaro; M Celli; L Viozzi; O Giardini
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

2.  Nanobiotechnological Nanocapsules Containing Polyhemoglobin-Tyrosinase: Effects on Murine B16F10 Melanoma Cell Proliferation and Attachment.

Authors:  Yun Wang; Thomas M S Chang
Journal:  J Skin Cancer       Date:  2012-11-08

3.  Towards resolving the enigma of the dichotomy of resveratrol: cis- and trans-resveratrol have opposite effects on TyrRS-regulated PARP1 activation.

Authors:  Megha Jhanji; Chintada Nageswara Rao; Mathew Sajish
Journal:  Geroscience       Date:  2020-11-27       Impact factor: 7.713

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.